Related Experiment Video
Updated: Jun 17, 2026
12:02
Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Myc and a Cdk2 senescence switch
Nature Cell Biology
|December 23, 2009
Abstract:
Cdk2 has been shown to have an unanticipated role in suppressing Myc-induced senescence. This has implications for how c-Myc overcomes failsafe mechanisms to induce tumorigenesis and suggests that the inhibition of Cdk2 may have therapeutic efficacy in the treatment of cancer.
Insights
Cyclin-dependent kinase 2 (Cdk2) unexpectedly suppresses Myc-induced senescence, a key step in cancer development. Inhibiting Cdk2 may offer a novel cancer therapy strategy by targeting this failsafe mechanism.
Area of Science:
- Molecular biology
- Cellular senescence
- Oncogenesis
Background:
- The oncogene c-Myc drives cell proliferation but typically induces senescence, a protective mechanism against tumor formation.
- Cellular senescence is a critical failsafe that prevents uncontrolled cell growth and tumorigenesis.
Discussion:
- This study reveals an unappreciated role for Cyclin-dependent kinase 2 (Cdk2) in overcoming c-Myc-induced senescence.
- Cdk2 activity appears essential for c-Myc to bypass senescence and promote tumor development.
- Understanding this interaction sheds light on how cancer cells evade growth suppression.
Key Insights:
- Cdk2 actively suppresses the senescence response triggered by c-Myc.
- This suppression mechanism is crucial for c-Myc-driven tumorigenesis.
- Targeting Cdk2 could be a viable strategy to restore senescence and inhibit cancer progression.
Outlook:
- Further investigation into the precise mechanisms of Cdk2 in senescence suppression is warranted.
- Exploring Cdk2 inhibitors for cancer therapy holds significant therapeutic potential.
- This finding may pave the way for novel combination therapies targeting cell cycle regulation in cancer.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.